PH14782A - Therapeutically active substituted dibenzyl ethers,method for preparation thereof and pharmaceutical compositions containing said ethers - Google Patents

Therapeutically active substituted dibenzyl ethers,method for preparation thereof and pharmaceutical compositions containing said ethers

Info

Publication number
PH14782A
PH14782A PH22475A PH22475A PH14782A PH 14782 A PH14782 A PH 14782A PH 22475 A PH22475 A PH 22475A PH 22475 A PH22475 A PH 22475A PH 14782 A PH14782 A PH 14782A
Authority
PH
Philippines
Prior art keywords
ethers
preparation
pharmaceutical compositions
compositions containing
therapeutically active
Prior art date
Application number
PH22475A
Other languages
English (en)
Inventor
Dante Nardi
Elena Massarani
Alberto Tajana
Mario Veroness
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of PH14782A publication Critical patent/PH14782A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PH22475A 1978-05-18 1979-05-10 Therapeutically active substituted dibenzyl ethers,method for preparation thereof and pharmaceutical compositions containing said ethers PH14782A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/78A IT1096361B (it) 1978-05-18 1978-05-18 Dibenzileteri sostituiti terapeuticamente attivi

Publications (1)

Publication Number Publication Date
PH14782A true PH14782A (en) 1981-12-09

Family

ID=11208025

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22475A PH14782A (en) 1978-05-18 1979-05-10 Therapeutically active substituted dibenzyl ethers,method for preparation thereof and pharmaceutical compositions containing said ethers

Country Status (29)

Country Link
JP (1) JPS605592B2 (fi)
AR (1) AR219596A1 (fi)
AT (1) AT372950B (fi)
AU (1) AU523053B2 (fi)
CA (1) CA1115718A (fi)
CH (1) CH639075A5 (fi)
DD (1) DD143608A5 (fi)
DE (1) DE2917244C2 (fi)
DK (1) DK153838C (fi)
EG (1) EG14345A (fi)
ES (1) ES480552A1 (fi)
FI (1) FI71309C (fi)
FR (1) FR2426047A1 (fi)
GB (1) GB2025395B (fi)
GR (1) GR68396B (fi)
HU (1) HU182565B (fi)
IE (1) IE48372B1 (fi)
IL (1) IL57245A (fi)
IT (1) IT1096361B (fi)
MX (1) MX5927E (fi)
NL (2) NL189255C (fi)
NO (1) NO152840C (fi)
NZ (1) NZ190412A (fi)
PH (1) PH14782A (fi)
PT (1) PT69537A (fi)
SE (1) SE444812B (fi)
SU (1) SU816399A3 (fi)
YU (1) YU112279A (fi)
ZA (1) ZA792015B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1155853A (en) * 1980-06-06 1983-10-25 Joseph A. Martin Imidazole derivatives and preparation thereof
EP0117811A3 (fr) * 1983-02-23 1987-06-03 Sanofi S.A. Compositions pharmaceutiques antifongiques utilisables par voie orale
FR2541114B1 (fr) * 1983-02-23 1986-04-11 Sanofi Sa Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
DE3413365A1 (de) * 1984-04-09 1985-12-19 Merz + Co GmbH & Co, 6000 Frankfurt Substituierte phenylethylderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
IT1200422B (it) * 1985-03-19 1989-01-18 Ripari Gero Ist Farm Biolog Composto con attivita' antimicrobia,sua preparazione e composizioni farmaceutiche che lo contengono
ES2249992B1 (es) 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
GB1475271A (en) * 1975-04-30 1977-06-01 Pfizer Ltd 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents

Also Published As

Publication number Publication date
GB2025395A (en) 1980-01-23
CA1115718A (en) 1982-01-05
JPS605592B2 (ja) 1985-02-12
IT7823546A0 (it) 1978-05-18
FR2426047B1 (fi) 1982-11-05
DE2917244C2 (de) 1985-09-05
SE7904319L (sv) 1979-11-19
NL930014I1 (nl) 1993-05-03
DE2917244A1 (de) 1979-11-22
NL930014I2 (nl) 1993-09-16
IT1096361B (it) 1985-08-26
GR68396B (fi) 1981-12-29
NL189255C (nl) 1993-02-16
IE48372B1 (en) 1984-12-26
IL57245A (en) 1983-02-23
NO791599L (no) 1979-11-20
SU816399A3 (ru) 1981-03-23
FI71309C (fi) 1986-12-19
DK196579A (da) 1979-11-19
GB2025395B (en) 1982-07-28
JPS54151974A (en) 1979-11-29
DK153838B (da) 1988-09-12
ZA792015B (en) 1980-04-30
SE444812B (sv) 1986-05-12
DK153838C (da) 1989-01-30
HU182565B (en) 1984-02-28
EG14345A (en) 1983-09-30
YU112279A (en) 1983-01-21
CH639075A5 (fr) 1983-10-31
FR2426047A1 (fr) 1979-12-14
MX5927E (es) 1984-08-29
NO152840C (no) 1985-11-27
NL7903872A (nl) 1979-11-20
IE790958L (en) 1979-11-18
DD143608A5 (de) 1980-09-03
FI791543A (fi) 1979-11-19
ES480552A1 (es) 1980-04-01
IL57245A0 (en) 1979-09-30
AU4714979A (en) 1979-11-22
NZ190412A (en) 1981-03-16
FI71309B (fi) 1986-09-09
AT372950B (de) 1983-11-25
AU523053B2 (en) 1982-07-08
PT69537A (fr) 1979-05-01
NO152840B (no) 1985-08-19
ATA345079A (de) 1983-04-15
AR219596A1 (es) 1980-08-29

Similar Documents

Publication Publication Date Title
CY1250A (en) N-heterocyclyl-4-piperdinamines,methods for their preparation and pharmaceutical compositions comprising them
DE2961289D1 (en) Pyrimidones, processes for their preparation and pharmaceutical compositions containing them
DE3061586D1 (en) Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
DE2966913D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE2966293D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
ZA794472B (en) Pyridazinone-substituted benzimidazoles,processes for their preparation,and pharmaceutical compositions thereof
DE2960954D1 (en) 1-aryloxy-3-nitratoalkylamino-2-propanols, process for their preparation and pharmaceutical compositions
DE2964209D1 (en) Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them
GB2019837A (en) N-Oxacyclic-alkylpiperidyl-diazacompounds, process for their manufacture and pharmaceutical compositions containing them
IL57599A0 (en) Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation
DE2962112D1 (en) Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
PT69207A (en) Process for preparing pharmaceutical formulations
PH14782A (en) Therapeutically active substituted dibenzyl ethers,method for preparation thereof and pharmaceutical compositions containing said ethers
ZA793131B (en) Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation
GB2044756B (en) Fluoro-amines processes for their preparation and pharmaceutical compositions containing them
ZA793682B (en) New piperidylbenzimidazolinone derivatives,processes for their preparation and pharmaceutical compositions containing them
GB2038802B (en) Aryltrifluoroethanols process for their preparation and pharmaceutical compositions containing them
IL57891A0 (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
DE2961285D1 (en) Frenolicin b, process for preparation thereof and pharmaceutical compositions containing it
DE3060079D1 (en) Spiro-quinolylhydantoins, process for their preparation and pharmaceutical compositions thereof
IL57754A0 (en) Benzopyranotriazoles,their preparation and pharmaceutical compositions containing them
DE2960503D1 (en) Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them
IL61099A (en) 9-deoxy-6,9alpha-imino-delta6,8-pgi analogues,process for their preparation and pharmaceutical compositions containing them
EP0018077A3 (en) Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines